Alternatives
Alternatives to Vabrinty 45 mg/0.375 mL extended-release injectable suspension
2 other presentations of Leuprolide 45 mg/0.375 mL extended-release injectable suspension
There are 2 alternatives to this medicine in the catalogue: the same active ingredient (Leuprolide), strength (45 mg/0.375 mL) and dosage form (extended-release injectable suspension) from 1 other makers or registers. The table compares packs, storage, lead time, documents and availability.
Side by side
The first row is the medicine you came from.
| Medicine | Manufacturer | Register | Packs | Storage | Lead time | Documents | Availability |
|---|---|---|---|---|---|---|---|
| Vabrinty 45 mg/0.375 mL extended-release injectable suspensionThis pageSubcutaneous | Uronova Pharmaceuticals | US FDA | 1 syringe of 0.375 mL | Cold chain | On request | — | Available on request |
| Eligard 45 mg/0.375 mL extended-release injectable suspensionSubcutaneous | Tolmar | US FDA | 1 syringe of 0.375 mL | Cold chain | On request | — | Available on request |
| Fensolvi 45 mg/0.375 mL extended-release injectable suspensionSubcutaneous | Tolmar | US FDA | 1 syringe of 0.375 mL | Cold chain | On request | — | Available on request |
Alternatives are listed for sourcing. Whether one medicine can replace another is the prescriber's decision, under the rules of the destination country.
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Back to Vabrinty 45 mg/0.375 mL extended-release injectable suspensionNot sure which maker to choose?
Request a quote for the medicine and we will propose the options that fit your country's import rules and timelines.